SCLXW · Scilex Holding Co · Executive Compensation
$0.05
At close · Oct 28
View the 10-Q filed Aug 14, 2026
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has concluded that the aforementioned conditions, among other things, raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Customer concentration
— top 4 customers 96% of revenue
4 customers — 96% of revenue (the three months ended June 30, 2026)
“The Company had four customers during the three and six months ended June 30, 2026, each of which individually generated 10% or more of the Company’s total revenue. These customers accounted for 96% and 95% of the Company’s revenue for the three and six months ended June 30, 2026, respectively, individually ranging from 22% to 27% and 19% to 27%.”
4 customers — 95% of revenue (the six months ended June 30, 2026)
“The Company had four customers during the three and six months ended June 30, 2026, each of which individually generated 10% or more of the Company’s total revenue. These customers accounted for 96% and 95% of the Company’s revenue for the three and six months ended June 30, 2026, respectively, individually ranging from 22% to 27% and 19% to 27%.”
4 customers — 80% of receivables (As of June 30, 2026)
“As of each of June 30, 2026 and 2025, these customers represented 80% and 99% of the Company’s outstanding accounts receivable, individually ranging between 16% and 37%, and 19% and 30% for respective periods.”
Market Cap
$17.41M
Shares
8.49M
Volume · Oct 28
11.61K
Avg daily vol (3M)
7651
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Henry Ji | Chief Executive Officer, President and Executive Chairperson | $3,069,495 |
| Stephen Ma | Chief Financial Officer, Chief Operating Officer, Senior Vice President and Secretary | $1,465,549 |
| Jaisim Shah | Former Chief Executive Officer, President and Director | $1,271,044 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jaisim Shah | Chief Executive Officer, President and Director | $1,266,574 |
| Henry Ji | Executive Chairperson | $1,261,651 |
| Stephen Ma | Chief Financial Officer, Senior Vice President, Secretary and Director | $613,821 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Henry Ji | Executive Chairperson | $33,919,750 |
| Jaisim Shah | Chief Executive Officer, President and Director | $7,373,977 |
| Stephen Ma | Chief Financial Officer, Senior Vice President, Secretary and Director | $1,900,705 |
| Elizabeth Czerepak | Former Executive Vice President, Chief Business Officer, Chief Financial Officer andSecretary | $1,503,278 |
| Elizabeth A. Czerepak | Former Executive Vice President, Chief Business Officer, Chief Financial Officer andSecretary | $1,503,278 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jaisim Shah | Chief Executive Officer, President and Director | $785,733 |
| Henry Ji | Executive Chairperson | $626,548 |
| Elizabeth A. Czerepak | Former Executive Vice President, Chief Business Officer, Chief Financial Officer andSecretary | $222,917 |
| Elizabeth Czerepak | Former Executive Vice President, Chief Business Officer, Chief Financial Officer andSecretary | $222,917 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jaisim Shah | Chief Executive Officer, President and Director | $881,389 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Stephen Ma | Chief Operating Officer | Appointed | 2025-10-07 |
| Stephen Ma | director | Appointed | 2025-09-26 |
| Jaisim Shah | director | Resigned | 2025-09-26 |
| Annu Navani | director | Resigned | 2025-09-26 |
| Henry Ji | Chief Executive Officer and President | Appointed | 2025-08-21 |
| Jaisim Shah | Chief Executive Officer and President | Resigned | 2025-08-21 |
| David Lemus | Non-Executive Director | Resigned | 2024-11-29 |
| Annu Navani, M.D. | Class II director | Appointed | 2024-07-25 |
| Henry Ji | Executive Chairperson of the Board | Appointed | 2023-09-22 |
| Henry Ji | Class III director | Appointed | 2023-09-22 |
| Yue Alexander Wu | Class II director | Appointed | 2023-09-22 |
| Jay Chun | Class II director | Appointed | 2023-09-22 |
| Laura J. Hamill | member of the Board of Directors | Resigned | 2023-09-22 |
| Stephen Ma | Chief Financial Officer | Appointed | 2023-09-22 |
| Elizabeth Czerepak | Executive Vice President, Chief Business Officer, Chief Financial Officer, Principal Accounting Officer, Principal Financial Off | Resigned | 2023-09-22 |
| David Lemus | Director | Resigned | 2023-08-31 |
| Jaisim Shah | Chief Executive Officer and President | Retired | 2023-08-31 |
| Dorman Followwill | Director | Resigned | 2023-08-31 |
| Laura J. Hamill | Director | Resigned | 2023-08-31 |
| Jaisim Shah | Director | Retired | 2023-08-31 |
| Henry Ji, Ph.D. | Executive Officer | Resigned | 2023-08-31 |
| Henry Ji, Ph.D. | Director | Terminated | 2023-08-31 |
| David Lemus | Class I director | Appointed | 2023-05-05 |
| Dorman Followwill | Class I director | Appointed | 2023-05-05 |
| Elizabeth Czerepak | Executive Vice President, Chief Business Officer, Chief Financial Officer and Secretary | Appointed | 2022-11-17 |
Leadership
- Henry Ji CEO, Chairman
- Jaisim Shah CEO, Board Member
- Elizabeth Czerepak CFO
- Stephen Ma CFO, COO, Board Member
- Annu Navani, M.D. Board Member
- David Lemus Board Member
- Dorman Followwill Board Member
- Jay Chun Board Member
- Laura J. Hamill Board Member
- Tien-Li Lee Board Member
- Tien-Li Lee, M.D. Board Member
- Tommy Thompson Board Member
- Yue Alexander Wu Board Member